Short- and long-term effects of dimethyl sulfoxide on mouse pancreatic islet B-cell function in vitro

Cryobiology
|June 1, 1982
PubMed

Insights

Dimethyl sulfoxide (DMSO) did not harm pancreatic islet B-cell function in vitro. Higher DMSO concentrations (1 M) reduced insulin and protein biosynthesis in acute tests, but not in culture.

Area of Science:

  • Endocrinology
  • Cell Biology
  • Cryobiology

Background:

  • Dimethyl sulfoxide (DMSO) is utilized as a cryoprotectant for the endocrine pancreas.
  • Potential cytotoxic effects of DMSO on pancreatic islet cells require investigation.

Purpose of the Study:

  • To evaluate the in vitro effects of DMSO on pancreatic islet B-cell function.
  • To assess DMSO's impact on glucose-stimulated insulin release and biosynthesis.

Main Methods:

  • Acute experiments exposing pancreatic islets to varying DMSO concentrations.
  • Islet culture experiments with DMSO-supplemented media.
  • Measurement of glucose-stimulated insulin release, glucose oxidation, and (pro)insulin/protein biosynthesis.

Main Results:

  • DMSO concentrations from 0.01 M to 0.5 M did not affect glucose-stimulated insulin release or islet glucose oxidation.
  • 1 M DMSO, but not 0.25 M, decreased glucose-stimulated (pro)insulin and total protein biosynthesis in acute experiments.
  • No significant effects on glucose-stimulated (pro)insulin biosynthesis were observed in islet culture experiments.

Conclusions:

  • DMSO in the range of 0.01-0.5 M appears safe for pancreatic islet B-cell function in vitro.
  • Higher DMSO concentrations may impact islet cell protein synthesis, particularly in acute exposure scenarios.

Related Concept Videos